《新股消息》招銀國際旗下Aquila Acquisition或成本港首間SPAC上市
招行(03968.HK)旗下招銀國際資產管理及公司管理層持股的AAC Mgmt Holding Ltd之Aquila Acquisition Corporation上載招股書,這將是首間特殊目的收購公司(SPAC)在香港申請上市。
根據招股書,Aquila Acquisition每股A類股份發行價是10元,每手入場費最少100萬元。公司收購目標主要是在亞洲,計劃與新經濟行業處於領先地位、有利長期增長前景、具差異化的價值主張及技術壁壘,以及具追溯效力的財務記錄等公司合併。
公司3名執董均爲招銀國際高層,獨董包括摩通中國投行部前主席龔方雄,上市保薦人爲摩根士丹利及招銀國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.